Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Tryptophan concentrations… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection

Artikel i vetenskaplig tidskrift
Författare Magnus Gisslén
M Larsson
Gunnar Norkrans
Dietmar Fuchs
Helmut Wachter
Lars Hagberg
Publicerad i AIDS Res Hum Retroviruses
Volym 10
Nummer/häfte 8
Sidor 947-51
Publiceringsår 1994
Publicerad vid Institutionen för invärtesmedicin, Avdelningen för infektionssjukdomar
Sidor 947-51
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Adult, Aged, Biopterin/analogs & derivatives/blood/cerebrospinal fluid, CD4 Lymphocyte Count, Female, HIV Infections/drug therapy/immunology/*metabolism, *HIV-1/metabolism, Homovanillic Acid/cerebrospinal fluid, Humans, Hydroxyindoleacetic Acid/cerebrospinal fluid, Immunoglobulin G/blood, Male, Methoxyhydroxyphenylglycol/cerebrospinal fluid, Middle Aged, Neopterin, Serotonin/blood, Tryptophan/*blood/*cerebrospinal fluid, Zidovudine/*therapeutic use
Ämneskategorier Mikrobiologi inom det medicinska området

Sammanfattning

Cerebrospinal fluid (CSF) and blood concentrations of indoleamines and catecholamines were analyzed in 14 HIV-1-seropositive individuals before antiviral treatment with zidovudine, after 3-14 months of treatment, and, in 8 of the patients, also after 14-30 months. The median pretreatment concentrations of tryptophan in CSF and blood were low (224 ng/ml and 6.0 micrograms/ml, respectively), but an increase in these values by an average of 40% in CSF and 23% in blood was seen after 3-14 months of zidovudine treatment (p < 0.01) and remained undiminished after 14-30 months of treatment. No significant change was observed in the 5-hydroxytryptamine (5-HT, serotonin) level in blood or in the CSF concentrations of the 5-HT metabolite 5-hydroxyindoleacetic acid (5-HIAA) and the dopamine metabolite homovanillic acid (HVA). The CSF concentrations of the noradrenalin metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) had decreased by 12% on average (p < 0.01) by the time of the second follow-up, that is, after 14-30 months of zidovudine treatment. A decrease in neopterin during antiretroviral treatment correlated with an increase in tryptophan (p < 0.01). The data suggest that an association between decreased immune stimulation and reduced tryptophan degradation in patients treated with zidovudine.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?